ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join us for the ACC Rockies Chapter Meeting from September 8-9, 2023 at the Hyatt Centric in Park City, Utah. For more information and to register, please visit: https://web.cvent.com/event/314c67f2-d26f-4ad9-bfd7-8011b1bd9dcb/summary
Latest in Cardiology from ACC.org
- CONFIRM2: AI-Guided QCT May Help Reduce CV Events in Patients With Suspected CADAI-guided Quantitative Coronary Computed Tomography Angiography (AI-QCT) may help guide tailoring of anti-atherosclerotic therapies or coronary interventional procedures to reduce cardiovascular events in patients with suspected coronary artery disease (CAD), based on findings from the CONFIRM-2 trial presented at TCT 2024.
- Percutaneous Coronary Intervention With a Bioadaptor Compared to a Contemporary Drug-Eluting StentThe goal of the INFINITY-SWEDEHEART trial was to compare the efficacy of the DynamX bioadaptor, a novel coronary implantable device, to a contemporary drug-eluting stent (DES) in the treatment of coronary artery disease requiring percutaneous coronary intervention (PCI).
- Effectiveness and Safety of Early Administration of Heparin at First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary InterventionThe goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).
- HELP-PCI: Unfractionated Heparin at First Medical Contact vs. the CathlabPretreatment of STEMI patients with a loading-dose of unfractionated heparin (UFH) at first medical contact (FMC) vs. in the catheterization lab (cathlab) was associated with improved spontaneous reperfusion of the infarct-related artery (IRA) without increasing the risk of major bleeding...
- DCB-BIF: DCB vs. NCB in Patients With Coronary Bifurcation LesionsIn patients with coronary bifurcation lesions undergoing provisional stenting, main vessel stenting with a drug-coated balloon (DCB) for a compromised side branch resulted in lower rates of major cardiovascular events at one year compared with use of a noncompliant balloon (NCB) for the side branch, according to findings from the DCB-BIF trial presented at TCT […]